Loading company…
ORANDBIO develops biomaterials for medical products.
Founded in 2024, ORANDBIO develops advanced biomaterials for hybrid medical products. It serves healthcare providers and research institutions in South Korea and plans to expand into Asia and North America. The company is based in Gyeonggi-do, South Korea. In May 2025, it raised KRW 300 million from Genaxis.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in